🇺🇸 FDA

Drug profile · INN

dipyridamole

DIPYRIDAMOLE

approved
US status
approved
Patents linked
5
News articles
0

Quick answer

dipyridamole (DIPYRIDAMOLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN dipyridamole
Brand DIPYRIDAMOLE
Route INJECTION
Formulation INJECTABLE

Related patents

Search patents →

  1. US 10973758

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10357453

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10322129

    Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10226420

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9901580

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is dipyridamole?

dipyridamole (DIPYRIDAMOLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for dipyridamole?

DIPYRIDAMOLE is a marketed brand name for dipyridamole. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dipyridamole?

dipyridamole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.